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Children, biobanks and the scope of parental consent
Kristien Hens*,1, Jean-Jacques Cassiman2, Herman Nys1 and Kris Dierickx1
The use of stored tissue samples from children for genetic research raises specific ethical questions that are not all analogous
to those raised when adult participants are concerned. These include issues with regard to consent, as it is typically a parent
who consents to the use of samples from children. In this paper, we discuss the scope of parental consent. This scope has a
temporal dimension and one related to the content of consent. It is not questioned that the temporal scope of parental consent
is limited and that young adults have the right to decide on the fate of their samples when they reach the age of maturity. With
regard to the content of consent, the question remains whether parents are allowed to give full broad consent to any possible
future research on the samples of their children. We argue that they should not be allowed to do so, based on two premises.
First, it is generally acknowledged that children have a right to express their own values and that they should be given the
opportunity to develop their own autonomy as they grow older. Second, research and science are not completely value-free
and some types of research may be more sensitive than other types. Children should be given the opportunity to express
their values also in this respect.
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INTRODUCTION
The use of stored tissue samples from children for genetic research
raises specific ethical questions that are not all analogous to those raised
when adult participants are concerned. The most obvious difference is
that for small children, at least, their DNA is used for research without
their own consent. As it is typically a parent who consents to the use of
the samples, it is unsure what the wishes of the child would be. The
issue of consent can furthermore be split up into some issues, which, in
themselves, have been more or less discussed in guidelines and ethics
literature. These issues involve questions about who should consent, the
right of a child to assent or dissent, the right of a child to withdraw their
data and the scope of parental consent. The scope of parental consent
has in its turn two dimensions. First, there is a temporal dimension: do
parents have the right to consent to the storage and use of pediatric
material ad aeternam or do children have to be asked to re-consent
when they reach the age of competence. Second, there is a dimension of
content. Do parents have the right to consent to any possible research
on the stored tissue samples of their children, the so-called broad
consent, or are they only allowed to give specific consent? Although a
substantial theoretical and empirical corpus already exists on the topic
of broad versus specific consent when adult participants are concerned,
the question is as of yet relatively untouched when participants are
children. In this paper, we shall first give an overview of the existing
literature with regard to biobanks, children and consent. We shall then
briefly describe the issue of broad versus specific consent as it is
discussed in the context of adults, and provide a reflection on how
this issue should be tackled when children are concerned.
CHILDREN AND CONSENT: EXISTING LITERATURE
A recent review has shown that guidelines on the use of stored tissue
samples from minors discuss the following issues: the fact that a parent
or legal guardian must consent, that a child’s assent and dissent should
be taken into account, and that children should be re-contacted as
young adults either when they are old enough to understand the
research or when they reach the age of competence.1 A review of the
literature has identified similar themes.2 There is consensus that
biological samples from children should not be used without consent
or at least notification, and that the people best suited to give this
consent are the parents or the legal guardian. In this respect, the
Organizations of Medical Science (CIOMS) guideline mentions, for
example, that ‘the parent or guardian who gives permission for a child
to participate in research should be given the opportunity, to a
reasonable extent, to observe the research as it proceeds, so as to be
able to withdraw the child if the parent or guardian decides it is in the
child’s best interest to do so’.3 Holm4 justifies this right of the parents to
consent by referring to the fact that biobank research in most cases does
not have negative effects on children. Also other authors seem to suggest
that consent by one parent is enough, although one may ask whether
the fact that genetic research is involved might complicate this matter, as
a child’s genes are shared with both the parents. However, many
children do not live with both biological parents, and a too stringent
requirement in this respect may hamper research. Hence, we think the
fact that both parents should consent to such research could be seen as a
best practice rather than an absolute rule.5
Several guidelines and the ethics literature mention the fact that
minors, as soon as they are mentally capable to do so, should be asked
to assent to research, and that their dissent should be taken into
account.1 For example, in papers from Holm and Helgesson,4,6 it is
stressed that older children should be asked to assent and dissent.
Helgesson links this to the fact that children develop autonomy by
being given the chance to exercise it to the degree they are capable of.
There is less certainty about whether there should be a fixed-age
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threshold for assent, or whether this should be evaluated on a case-by-
case basis. A qualitative study based on interviews with professionals
in the field of stored tissue samples from minors has suggested that
professionals do not believe in fixed-age thresholds and that they see
legal requirements to ask small children to sign papers as unrealistic
and bureaucratic.7 Ashcroft et al8 have also suggested that maturity is
a better criterion than age because the capacity to assent is dependent
on social context and personal experience. We agree with this stance.
We also believe that in many cohort studies with children or studies in
the context of specific diseases, there is plenty of opportunity for
informal assessments of maturity, as in such cases there is frequent
contact between researchers and children. In any case, all children, also
very small ones, have a right to information at a level they can
understand. It is also the task of the professional, be it a researcher, a
clinician or a research nurse, together with the parents, to assess the
value of a child’s dissent. On one hand, many children may have an
unreasonable fear of certain procedures, a fear, which might be easily
overcome by rewards, such as a sticker or small present, from the
researcher or the parent. On the other hand, no child should be
subjected to procedures she obviously dislikes, whatever the parents’
or researcher’s noble aims be to aid in the progress of science. And of
course this assumes that an ethics committee, with a pediatrician as
member, has already assessed the burden of the procedures and
decided that it is reasonable.
An important question with regard to consent to research on
samples that are stored over a longer period of time is related to the
scope of consent. This scope has two dimensions: a temporal one and
one related to content. The temporal dimension is discussed to some
extent in existing literature. Guidelines and the literature agree that the
temporal scope of parental consent is valid until the child reaches the
age of competence.2,1 In this respect, CIOMS mentions that ‘If such
research subjects, including children, become capable of giving inde-
pendent informed consent during the research, their consent to
continued participation should be obtained’.3 Burke and Diekema,9
for example, are in favor of such re-consent because this would allow
minors to participate more as they grow older, a thought, which is
supported by empirical research.10 However, this may be impossible in
some cases: Samples may be stored for many years, and there may be
no possibility to re-contact the children. One qualitative focus group
study has suggested that in this case, a best effort to re-contact young
adults is sufficient, but that it is still seen as a sign of respect from
researchers.11 Another study, however, found that children should be
re-contacted.12 In any case, there was consensus that minors should be
allowed to withdraw their samples and data from a study for which
their parents consented. Holm4 states in this respect that as children
have not been able to autonomously consent and give up the right to
withdraw at the moment of donation, the right to withdraw for
children is more important than the right to withdraw for adult
donors.
We agree that in principle, biobankers should make an effort to
re-contact young adults for reconsent once they are capable of giving
consent. We also agree that young adults have the right to withdraw
their samples and data. In this respect, the temporal scope of parental
consent is limited.
A topic much less discussed in the context of pediatric biobanks is
that of the content of parental consent. Are parents allowed to give
‘broad consent’ to any possible future genetic research on their
children’s samples or should this consent be better specified. In next
paragraphs we shall describe the existing discussion of broad versus
specific consent in general, and then specify why we think the issues
are different when participants are minors.
BROAD VERSUS SPECIFIC CONSENT
Traditional informed consent, which assumes the fully informed, mostly
written consent of a participant to a specific research proposal, has
become the theoretical standard in research bioethics, as it is deemed
the most appropriate sign of respect for the autonomy of an individual.
However, it is not specifically well suited for the inclusion of samples in
biobanks. Such biobanks form a resource for future research, the
specific content and extent of which, at the time of storage, are often
unknown. Therefore, it is argued that consent for such research is never
truly informed.13 But re-contacting donors for consent to each and
every different research protocol is costly and may hamper the advance-
ment of research.14 Some have argued that these technical difficulties do
not provide a sufficient ethical ground for broad consent.15 However, it
has also been argued in the theoretical literature that principles of justice
and solidarity can justify consent procedures, which diverge from the
ideal standard of previous, free, informed and explicit consent.16 Such
principles are based on the concept of medical science as a ‘collective
good’, a notion, which may be true in the case of some research aims,
but may that be naı¨ve in other cases.17 Also, there is a range of
possibilities between giving true informed and specific consent, and
completely blanket consent, which implies that no restrictions are put
on the scope and direction of the possible research.18 Broad consent, as
it is now often deployed, is still subject to certain restrictions, and not
completely analogous with ‘blanket consent’. A study by Elger et al19
regarding the European guidelines has shown that many of them take
the view that general or broad consent is acceptable for unspecified
future research use, if two conditions are met: a research ethics
committee approves future projects and participants have the right to
withdraw their samples at any time. This viewpoint is shared by
Hansson,20 and is backed up by many empirical studies. Indeed, a
meta-review of Wendler et al21 of empirical studies regarding this topic
has shown that a majority of donors do not object to broad consent,
although other studies have pointed out that individuals want ongoing
choices and control over access to their samples and information.22
Furthermore, in practice, broad consent seems to be the route taken
by most biobanks to-date as well. An analysis of 52 European Network
for Genetic and Genomic Epidemiology (ENGAGE) consent forms and
information documents has shown that 27 of the studies involved used
broad consent and 25 used specific consent, and that information sheets
of 35 studies mentioned that the samples would be used for DNA
extraction or genetic analysis. The information sheets of the remaining
17 did not mention genetic research per se but only biological
research.23 The seminal UK biobank states in its consent form:
‘I give permission for long-term storage and use of my blood
and urine samples for health-related research purposes (even
after my incapacity or death), and relinquish all rights to these
samples which I am donating to UK Biobank. (http://www.uk-
biobank.ac.uk/docs/2006ConsentformA.pdf)
Hence, the only limitation as to the content of the research being
carried out is that it has to be ‘health-related’ research. The Estonian
Gene Bank (http://www.geenivaramu.ee/index.php?id¼100) has similar
provisions, but it is even broader in specifying the type of research, in that
it refers to ‘The use thereof for genetic research, public health research
and statistical and other purposes in accordance with the law.’ Hence,
they ask consent to virtually any type of research that is legally allowed.
BROAD VERSUS SPECIFIC CONSENT IN PEDIATRIC
BIOBANKS
We believe that the issue of broad versus specific consent is even more
complicated when participants are minors, as their parents provide
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consent for them. In the next paragraphs, we shall first describe the
scarce literature that exists on this topic. Next, we shall discuss in more
depth why we think this issue is further complicated and needs
thorough reflection. We admit that the definition of ‘broad consent’
is in itself problematic, as it can refer to a whole range of items, from
complete ‘blanket’ consent, to more restricted, but still fairly general
consent. We shall use the term ‘broad consent’ as it is used in the
literature, to refer to consent to unspecified future research, but under
the supervision of a research ethics committee, whereas participants
have the right to withdraw at any time.
Broad versus specific consent in pediatric biobanks: empirical
studies
Not much study has been carried out with regard to the question of
broad consent in pediatric biobanks. An overview of consent proce-
dures in six cohort studies has shown that ‘broad’ consent is typically
requested. One could argue, however, that that this is not really
blanket consent, as the specific context of these studies allow for
frequent contact between researchers, children and parents, thereby,
providing many opportunities to reconsent.24 An interview-based
study with professionals associated with pediatric biobanks has
shown that they would prefer ‘broad consent’, but also think that if
the research takes a too big step away from the original protocols,
ethics committees should decide whether re-consent is necessary.7
These studies suggest a discrepancy between what is formally con-
sented (which is fairly broad and includes any potential future
research) and the actual practices researchers feel comfortable with.
There seems to be a moral awareness among researchers that leads
them to believe that re-consent is necessary for research that is very
different from what is possible at the time of inception of the biobank.
Hence, their interpretation of what is broad consent is more restricted
than what the formal definition would suggest. Moreover, a survey
among Belgian professionals has shown that for research on stored
tissue samples from children, although there is still support for broad
consent (47.6%), more professionals would support specific consent
(79.4%).25 And a survey of Helgesson et al26 of parents with and
without earlier research experience showed that parents thought
research studying the possible prevention of disease and research
exploring the impact and importance of environmental factors were
the most important followed by research into the role of genetic
factors behind disease development. The least important research was
deemed to be on medical substances and special groups of children.
These findings suggest that parents (and possibly the general public)
hold a certain value scheme about science, and that not all research is
equally important to them. That being said, a survey by Neidich et al27
shows that women who were willing to enroll their children in a
pediatric biobank put very little restrictions on the type of research
that could be performed on these samples, with the exception of
cloning.
TWO PRESUPPOSITIONS
We accept that, for biobanks containing only adult material, it may be
perfectly acceptable that at time of donation some form of general
consent is requested. We agree that this should not be completely
blanket consent in that certain conditions should be met. Sensible
conditions are the requirement that there is ethics committee over-
sight of the research proposals and donors have the right to withdraw
their samples at any time. We also accept that parents are entitled to
make certain decisions for their children, and that this is a fact of life.
This fact seems not to be questioned by children either.28,11 Indeed,
empirical studies on the enrollment of children in genetic biobank
research have shown that overall parents are happy to enroll their
children in biobank research, provided it is not burdensome or risky,
and that it can aid other children.11,27 We agree that the decision to
donate biological samples from children to genetic research is not too
radical, provided that proper governance structures and data protection
are put in place.29 In this respect, we disagree with authors who either
argue that parents do not have the right to consent to the inclusion of
their children’s samples in biobanks,30 or that sharing of samples
between research institutes should await the children’s full consent.31
Broad parental consent and its limitations
We question the fact that the right to make decisions on behalf of
children should include the right to give broad consent to any future
unspecified genetic research on these samples. This belief is based on
the idea that children are allowed to develop and express their own
values, as they grow older, and that we should respect these values, and
on the fact that medical research is not value-free. We shall elaborate
on these ideas in the next paragraphs. In this respect, our concept of
informed consent is not so much based on a contractual approach, in
which the conditions and risks of participation are explained to
participants who can then decide for themselves whether they
would take these risks or not.32 Rather, it is based on a concept of
consent as acknowledgement that individuals may hold certain values
regarding research and on an acknowledgement of respect for these
values. In this regard, our concept is linked with traditional concepts
of consent, as a sign of respect of someone’s autonomous right to hold
certain values and his or her dignity as human person. This need not
contradict with the assumption that biobanks and medical research
can appeal to the solidarity of participants and, therefore, deploy
consent strategies that are not completely analogous to informed
consent. An autonomous person is always also a member of a
community.33 In this regard, respect for values of individuals does
not necessarily mean that each and every decision must be left to the
individual but that circumstances can influence the decision of the
individual. However, we do believe that children are a special case for
that matter.
The fact that parents should not be allowed to give full broad consent
to any possible research on their children’s samples is linked to the
special status of children. They are gradually becoming more autono-
mous in their thinking and are acquiring their own values as they grow
older. Moreover, next to being a transitory phase toward adult auton-
omy, childhood is now more and more seen as a phase that is valuable
and deserve respect in itself. Children may have different opinions and
beliefs from those they shall have as adults, but this in itself is seen as
something that should be respected.34 These opinions have now also
been laid down in the Convention on the Rights of the Child:35
(article 12) 1. States Parties shall assure to the child who is
capable of forming his or her own views the right to express
those views freely in all matters affecting the child, the views of
the child being given due weight in accordance with the age and
maturity of the child.
With genetic research on biobank samples this poses specific issues.
Typically, biobanks form a resource for potential future research,
which is unknown at the time of the storage of samples. Although
this may be perfectly acceptable for adults, who make the decision for
themselves, for children some types of research may be too definite. As
has been argued by Feinberg, children have a right to an open future.36
Choices made for children should not be too definite; in that,
they should not prevent the children from making different choices
themselves as soon as they are capable of doing so.
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An exception is made if such choices are deemed in the best interest of
the child, in which parents are considered to be allowed to make
definite choices, even contrary to the wishes of the child. Examples of
such choices are life-saving operations or vaccinations. However, when
parents give broad consent to any possibly future genetic research on
the samples of their children, the best interest argument is not
applicable. Moreover, such choice prevents children from making
their own choices and revising these choices as they learn to become
more autonomous. In case of biobanks, risks quoted are often related
to privacy breaches and third-party access, such as the use of
information by insurers or employers. As we have argued elsewhere,
we think that such risks should be tackled by good governance and
policy structures.29 But genetic privacy in itself is a value, regardless of
the risks associated with third-party access. Hence, the publication of
full genomes, which might reveal increasingly more information about
the individual concerned as science progresses, should be up to that
individual alone, and should not be considered part of any broad
consent by parents. In this respect, Lunshof18 has described the idea of
‘open’ consent. We think that such ‘open’ consent can never be asked
from parents for their children.
A second factor, which is related to the growing autonomy of
children, is the fact that science and research are not completely value-
free. Although parents may, in good conscience, consent to future
research on the samples of their children out of a feeling of altruism,
and in line with the solidarity argument, ‘for the benefit of science’,
their children may have a different opinion on what constitutes a valid
research aim. As we have pointed out above, existing consent forms
are vague as to the meaning of what is included in broad consent, and
contain a general reference to either genetic or medical research. But
does research investigating the relationship between genes and IQ or
certain behavior fit this description? If the primary aim of a research
proposal is the development of a prenatal test possibly leading to
pregnancy termination, does it fall under the denominator ‘health-
related research’? As opinions vary on that, and are personal, it is
indeed impossible to draw sharp dividing lines between what kind of
research is comprised in a ‘broad consent’ and what is not, if the latter
is not further specified or only described in general terms. We believe
that genomic research, which has the potential to develop treatment or
diagnosis for serious diseases, is legitimate, and not something many
people would question. Hence, researchers and biobankers can appeal
to solidarity of participants, including parents and children if such
research is undertaken.16 But does research focusing on IQ, behavior
or performance enhancement fit this description? We think that,
although parents might be asked for consent to such research
specifically, this should not be considered as part of the general
consent for pediatric biobanks, and that some form of reconsent or
notification is necessary in this case.
Challenges
There are some practical difficulties associated with our approach. We
acknowledge that it is impossible to provide strict rules as to which
type of research is included in the original parental consent and which
research is possibly sensitive. We believe that the initial consent can be
sufficiently broad to include research, which intends to prevent and
treat relatively burdensome diseases. Ethics committees that supervise
research proposals should evaluate whether the research falls under
this category. Furthermore, biobank participants or their parents
should have access to descriptions of goals and modalities of research,
and have the opportunity to opt out of contributing. This can be
carried out through a newsletter or a central website. As is already
argued by Caulfield and Kaye15 for re-consent, the informatization of
samples and medical data could also allow easy notification of
participants through techniques such as E-mails or phone messages.
Although this still may constitute an administrative overhead for
researchers, who are then obliged to formulate proposals also in lay
terms, it is a sign of respect for participants and their parents and
ultimately it will enhance trust in, and education about the, biobank
and science, in general.
A further difficulty is related to the difference between assent and
consent. We do not suggest that parents cannot consent to research on
tissue samples from their children if this research may be sensitive for
some, only that they or their children should be given the opportunity
to object to inclusion of their samples in such potentially sensitive
research. We argue that there is a need for respect for the values of
parents and specifically for children. Given the importance that should
be given to the values and opinions of the children, they should be
asked for their opinion and, if they are old enough, asked to assent as
well. Practically, this respect may be translated in different forms
depending on the type of collection. Most research on stored tissue
samples from children requires extensive follow-up and hence fre-
quent contact with parents and children. This will make it easier for
researchers or associated clinicians to discuss the various types of
research and assess the maturity of children. In case of research on
stored tissue samples and data that does not require additional
contacts after recruitment, parents and children should still be notified
of new research using new techniques described above. Moreover, if
there is limited contact between researcher and families, for example,
because there was a one-time donation of a sample and no further
information is gathered from the donors, a fixed-age threshold can be
used at which young persons are contacted for full consent.
At which point, then, does the opinion of the young person become
the only one that should be taken into account? There is no fixed
answer to that, but we do believe that for the question of re-contacting
and re-consenting to specific research protocols, the opinion of the
child matters most. As there is not much risk involved, and as this is
not a question of acting in the (medical) best interest of a child, such
consent may be an excellent opportunity for children to reflect on
their own values and exercise their growing autonomy. Hence,
children who are below the legal age of consent may be asked for
full consent in this case as well.
We have assumed that samples and information in biobanks are not
completely de-identified and that re-contacting donors is possible. We
admit that when samples are completely anonymized, it is impossible for
biobank participants to be re-contacted or to withdraw samples. The
issues related to complete anonymization have been discussed in some
depth in the literature on biobanks. We believe in most cases, a coded
system rather than complete anonymization is now used, as this provides
sufficient privacy protection and takes away some of the drawbacks of
complete anonymization. This may be especially true for pediatric
research, as in most cases this requires some follow-up of participants.
CONCLUSION
One of the ethics issues associated with pediatric biobanks and genetic
research on stored tissue samples from children is the question about
the scope of parental consent. This scope has two dimensions. First,
there is a temporal one. It is generally acknowledged that children, as
they grow older and approach a certain level of maturity, should be
allowed to have a say on what happens with their samples and possibly
withdraw them from a collection. Hence, the temporal scope of
parental consent is limited. Next, there is also the aspect of content.
Should parents be allowed to give broad consent to any genetic
research on their children’s samples or only give specific consent?
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We have argued that, given the specificity of childhood, in which
children are gradually acquiring their own values and developing their
own autonomy, and the fact that medical research and science is
value-laden, parents can give permission for research, which intends to
understand and treat diseases. However, research that is more sensi-
tive, such as behavioral research or IQ-related research, or research
that would infringe the right to privacy, such as the publication of a
child’s full genome, would not be part of the original parental consent.
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